| BCAAs in Concussion 3.0 (NCT07670195) | Akiva Cohen | 2026-07-01 |
| Clinical Trial Evaluating the Efficacy and Safety of TQB3454 Tablets in Participants With Advanced Solid Tumors (NCT07738679) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2026-07-01 |
| SHR-1701 for Induction and Consolidation Therapy in Unresectable Stage III Non-Small Cell Lung Cancer (NCT07619911) | Fudan University | 2026-07-01 |
| Trastuzumab Rezetecan(SHR-A1811) Combined With Ivonescimab (AK112) in Locally Advanced or Metastatic Non-small Cell Lung Cancer Harboring HER2 Gene Abnormalities (NCT07630077) | Sun Yat-sen University | 2026-07-01 |
| A Three-part First-in-human Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB-UCN2 in Healthy Lean and Obese Participants and Participants With T2D (NCT07702890) | Gubra A/S | 2026-07-01 |
| Safety and Dose-Response of Bletilla Formosana in Prediabetic Subjects (NCT07704944) | Chang Gung Memorial Hospital | 2026-07-01 |
| Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma (NCT07529808) | BigHat Biosciences, Inc. | 2026-07-01 |
| Dapagliflozin Add-on in Unresectable HCC With Metabolic Syndrome (NCT07729592) | Sun Yat-sen University | 2026-07-01 |
| Study of EPN-701 for the Treatment of Calciphylaxis (NCT07583745) | Sagar U. Nigwekar, MD, MMSc | 2026-07-01 |
| Oritavancin for Treatment of Serious Cardiac Infections (NCT07550595) | Kirby Institute | 2026-07-01 |
| Orlistat Plus Progestin for Fertility-Sparing Treatment of Endometrial Cancer or Atypical Hyperplasia (NCT07714070) | Peking University People's Hospital | 2026-07-01 |
| A Clinical Study of TQB2930 Injection and Chemotherapy With or Without Bevacizumab in the Treatment of Advanced Colorectal Cancer (NCT07653685) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2026-07-01 |
| MSC-Exosome Therapy for Frontotemporal Dementia (NCT07638813) | Ruijin Hospital | 2026-07-01 |
| A Clinical Trial of NS-863 in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) (NCT07441278) | NS Pharma, Inc. | 2026-07-01 |
| Valproate for the Treatment of Residual Amblyopia (NCT07226141) | Boston Children's Hospital | 2026-07-01 |
| Mindfulness-based Psilocybin Therapy for PTSD (NCT07104916) | Anthony P King | 2026-07-01 |
| Study on the Efficacy and Safety of VA Regimen Compared to "3+7" Regimen in Newly Diagnosed AML With NPM1 or IDH1/IDH2 Mutations (NCT07664839) | Shen yang | 2026-07-01 |
| Furmonertinib Plus Radiotherapy for EGFR+ NSCLC With Pleural Effusion (NCT07482605) | Jiangmen Central Hospital | 2026-07-01 |
| Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease (NCT07651319) | The Methodist Hospital Research Institute | 2026-07-01 |
| Palmitic Acid and Human Microvascular Function (NCT06683534) | Medical College of Wisconsin | 2026-07-01 |
| Proof of Concept Study to Assess Safety and Efficacy of Phage Therapy in Hip or Knee Prosthetic Joint Infections Due to Staphylococcus Aureus Treated by DAIR. (NCT06605651) | Phagenix | 2026-07-01 |
| Becotatug Vedotin Plus Pucotenlimab for Advanced Biliary Tract Cancer, Phase II (NCT07649980) | HuiKai Li | 2026-07-01 |
| A Study of BL-M14D1 in Combination With Atezolizumab in Patients With Extensive-stage Small Cell Lung Cancer (NCT07654400) | Sichuan Baili Pharmaceutical Co., Ltd. | 2026-07-01 |
| Adebrelimab or Retlirafusp Alfa Plus Recaticimab and Chemotherapy for Resectable NSCLC (NCT07567326) | Peking University Cancer Hospital & Institute | 2026-07-01 |
| Sacituzumab Tirumotecan in Previously Treated TROP2-Positive Advanced Biliary Tract Cancer (NCT07701122) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2026-07-01 |
| C-CAR168 CAR T Cell Therapy for Refractory Autoimmune Disease (NCT06935474) | AbelZeta Inc. | 2026-07-01 |
| Phase II Trial of SFRT Plus Chemo-immunotherapy for LA-NSCLC With Suboptimal Neoadjuvant Response (NCT07670715) | Tianjin Medical University Cancer Institute and Hospital | 2026-07-01 |
| Tirzepatide for the Treatment of Cannabis Use Disorder (NCT07265752) | Brigham and Women's Hospital | 2026-07-01 |
| Sacituzumab Tirumotecan Plus Immunotherapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT07686588) | Biying Chen | 2026-07-01 |
| A Feasibility Study of Supplemental Oxygen to Improve Pulmonary Hypertension in People With Intradialytic Hypoxemia (NCT06327373) | Duke University | 2026-07-01 |
| A Study of BEBT-908 in Combination With Chemotherapy in Patients With Previously Untreated Peripheral T-Cell Lymphoma (PTCL) (NCT07676175) | BeBetter Med Inc | 2026-07-01 |
| Dose-Finding Study of HUC1-394 in Participants With Dry Eye Disease (NCT07656688) | Huons Co., Ltd. | 2026-07-01 |
| BPI-361175 Tablets in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT05393466) | Xcovery Holdings, Inc. | 2026-07-01 |
| BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder (NCT07596212) | University of Illinois at Chicago | 2026-07-01 |
| Efficacy of Botulinum Toxin Versus Placebo on Pain and Health Related Quality of Life of Patients With Piriformis Muscle Syndrome (NCT07624045) | Centre Hospitalier Universitaire de Nīmes | 2026-07-01 |
| Oral Versus Intravenous Magnesium on Emergence Delirium (NCT07655817) | Tanta University | 2026-07-01 |
| A Trial to Compare Treatment With Surlorian (ARM210, S48168) to Placebo in Effects on Muscle Strength and Safety in Adults With Autosomal Dominant RYR1-related Myopathy (NCT07560020) | RyCarma Therapeutics, Inc. | 2026-07-01 |
| A Long-term Study of KT-621 Administered Orally to Participants With Asthma Previously Enrolled in a KT-621 Asthma Study (NCT07677059) | Kymera Therapeutics, Inc. | 2026-07-01 |
| Haploidentical Donor Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Neuroblastoma (NCT07635056) | Children's Hospital Medical Center, Cincinnati | 2026-07-01 |
| Brachytherapy Followed by Nivolumab Prior to Surgery in Rectal Cancer (NCT07645118) | Dr. Te Vuong | 2026-07-01 |
| TPO-RA Plus Baricitinib vs. TPO-RA for ITP (NCT07669675) | Peking University People's Hospital | 2026-07-01 |
| Chemoradiotherapy and SHR-1701 in Patients With Unresectable Gastric Cancer (NCT07689851) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2026-07-01 |
| PTC-guided Neoadjuvant Therapy For Muscle-invasive Bladder Cancer (NCT07690878) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2026-07-01 |
| Clinical Trial to Observe the Effects of Tamoxifen on Testosterone Recovery in Medically Castrated Prostate Cancer Patients (NCT07535905) | University Health Network, Toronto | 2026-07-01 |
| Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study (NCT07486869) | University of Miami | 2026-07-01 |
| Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0) (NCT07513324) | Dana-Farber Cancer Institute | 2026-07-01 |
| Iparomlimab and Tovorilimab (QL1706) Combined With Bevacizumab and Chemotherapy as Neoadjuvant Therapy for Advanced Ovarian Cancer (NCT07663513) | Fudan University | 2026-07-01 |
| A Study to Evaluate MAR002 for Acromegaly (NCT07641179) | Marea Therapeutics | 2026-07-01 |
| Use of Bile Acid Binding Resins to Decrease PFAS Levels Via Colesevalem in Veterans Study (NCT07592858) | University of Rhode Island | 2026-07-01 |
| Mannatide Combined With CAPOX and Tislelizumab for Advanced Gastric Cancer. (NCT07655661) | Ming Liu | 2026-07-01 |
| Stress-buffering and Sleep Disturbance-resilient Effects of a Dual Bifidobacterium Longum Combination Under Short-term Travel (NCT07511855) | Min-Tze LIONG | 2026-07-01 |
| Iparomlimab and Tuvonralimab Plus Paclitaxel and Platinum as Neoadjuvant Therapy for Locally Advanced Cervical Cancer (NCT07646301) | Sun Yat-sen University | 2026-07-01 |
| A Clinical Trial Comparing TQC3927 Inhaled Powder With Glycopyrronium Bromide and Formoterol Inhaled Aerosol (Biovoping® Lingchang®) for the Treatment of Chronic Obstructive Pulmonary Disease (NCT07633314) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2026-07-01 |
| Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial (NCT07650240) | Mayo Clinic | 2026-07-01 |
| A PHASE IB/II STUDY TO EVALUATE SAFETY AND EFFICACY OF BEXMARILIMAB IN COMBINATION WITH DOXORUBICIN IN METASTATIC SOFT-TISSUE SARCOMA (NCT07460986) | MedSIR | 2026-07-01 |
| TAVNEOS for Otolaryngologic Manifestations of Granulomatosis With Polyangiitis (NCT07176546) | Robert Spiera, MD | 2026-07-01 |
| Study of Psilocybin Under Anesthesia Controlled by EEG (NCT07479550) | Stanford University | 2026-07-01 |
| A Phase 1/2 Study of Safety and Tolerability of MT-125 With Chemoradiation in Patients With Newly Diagnosed MGMT Methylated Glioblastoma (NCT07604285) | Myosin Therapeutics Inc. | 2026-07-01 |
| Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation (NCT07501078) | Muhammad N Aslam, MD | 2026-07-01 |
| VEL-101 to Prevent Rejection After Kidney Transplantation (NCT07290777) | Veloxis Pharmaceuticals | 2026-07-01 |
| A Study of VV-14303 for the Treatment of Metabolic Dysfunction-associated Steatohepatitis (MASH) (NCT07732400) | Kriya Therapeutics, Inc. | 2026-07-01 |
| A Phase II Trial of Tumour Infiltrating Lymphocyte Adoptive Cell Therapy in Patients With Immune Checkpoint Inhibitor Resistant Unresectable or Metastatic Melanoma (NCT07651618) | East Metropolitan Health Service, Australia | 2026-07-01 |
| Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors (NCT07226713) | Medical College of Wisconsin | 2026-07-01 |
| A Phase IIa Study of Vitamin D3 Tolerogenic Dendritic Cells (tolDC) for Multiple Sclerosis (NCT07020715) | University Hospital, Antwerp | 2026-07-01 |
| The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease (NCT07610369) | Yale University | 2026-07-01 |
| Cemiplimab With Fianlimab for Resectable Non-Metastatic Colon Cancer (NCT07224022) | John Strickler, M.D. | 2026-07-01 |
| A Novel Cold and Flu Herbal Blend for Reducing the Duration and Severity of the Common Cold (NCT07642648) | RDC Clinical Pty Ltd | 2026-07-01 |
| SAMe in Prevention of Oxaliplatin-associated Liver Injury (NCT06258525) | Cedars-Sinai Medical Center | 2026-07-01 |
| MRI-Guided Adaptive Radiotherapy for Limited Peritoneal Metastases (MARACAS Trial). (NCT07593261) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2026-07-01 |
| Terazosin And Metabolic Energetics in Parkinson's Disease (NCT07464028) | Nandakumar Narayanan | 2026-07-01 |
| Study to Evaluate the Use of Triheptanoin in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD) (NCT07097311) | Jerry Vockley, MD, PhD | 2026-07-01 |
| Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria (NCT07512596) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2026-07-01 |
| Precision Medicine for Immunotherapy-Resistant Advanced Esophageal Cancer (NCT07653451) | Peking University Cancer Hospital & Institute | 2026-07-01 |
| Terbium 161 PSMA in Lutetium-177 PSMA Naive Patients (NCT07441837) | Ankara University | 2026-07-01 |
| A Surgical Procedure (Total Pancreatectomy) With a Transplant Procedure (Islet Cell Autotransplantation) for the Treatment of Chronic Pancreatitis and Benign Pancreatic Tumors (NCT05453851) | OHSU Knight Cancer Institute | 2026-07-01 |
| Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial) (NCT05554419) | National Cancer Institute (NCI) | 2026-07-01 |
| Oral CBP-0276 or Placebo in Adults With Active Psoriatic Arthritis (PsA) (NCT07706530) | Clarent Biopharma, Inc. | 2026-07-01 |
| Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial (NCT07396155) | PT. Prodia Stem Cell Indonesia | 2026-07-01 |
| Safety and Efficacy of Edaravone Dexborneol Sublingual Tablets for Blood-Brain Barrier Dysfunction in CADASIL (NCT07692399) | Huashan Hospital | 2026-07-01 |
| A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia (NCT07423546) | New York State Psychiatric Institute | 2026-07-01 |
| Lumacaftor Yields Reversal of Impaired Cerebral Blood Flow in Heart Failure Patients (NCT07695090) | Qanatpharma AG | 2026-07-01 |
| A Dose Optimization/Expansion Study of SAR445877 in Adult Chinese Participants With Advanced Gastric or Gastroesophageal Junction Cancer (NCT07692204) | Sanofi | 2026-07-01 |
| Efficacy and Safety of Benvitimod Cream in Cutaneous T-Cell Lymphoma (NCT07658924) | Peking University First Hospital | 2026-07-01 |
| Testing Mitazalimab in Combination With Standard Chemotherapy in Immunotherapy Resistant Advanced Biliary Tract Cancers (NCT07437287) | UNICANCER | 2026-07-01 |
| Revumenib, Azacitidine, and VENetoclax in Newly Diagnosed KMT2A-Rearranged AML (NCT07605949) | UNC Lineberger Comprehensive Cancer Center | 2026-07-01 |
| Randomized Evaluation of Istaroxime for Stabilization in Acute Heart Failure-Cardiogenic Shock (NCT07583446) | Seismic Pharmaceuticals Operations LLC | 2026-07-01 |
| Reducing Inflammation to Improve Vascular and Bone Outcomes With Low-dose Colchicine in CKD (NCT07654231) | University of Texas Southwestern Medical Center | 2026-07-01 |
| A Study Comparing BL-M07D1 With DS-8201 in Patients With HR-Positive, HER2-Low Expressing Recurrent/Metastatic Breast Cancer (NCT07678957) | Sichuan Baili Pharmaceutical Co., Ltd. | 2026-07-01 |
| Study of Sacituzumab Govitecan With Atropine to Improve Tolerability in Advanced TNBC and HR+/HER2- Breast Cancer (NCT07367178) | MedSIR | 2026-07-01 |
| Study to Determine Optimal Dose, Evaluate the Efficacy and Safety of PRG-N-01 in Patients With Neurofibromatosis Type II (NCT07131722) | PRG Science & Technology Co., Ltd. | 2026-07-01 |
| Evaluation and Outcomes of SAVI Scout MD for Localized Breast Surgery (NCT07686250) | H. Lee Moffitt Cancer Center and Research Institute | 2026-07-01 |
| Sun Yat-Sen Treatment Strategy for Enhancing Response in Muscle-invasive Bladder Cancer (NCT07717242) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2026-07-01 |
| Adding Effect of Cross-linked Hyaluronic Acid to Microneedling After Coronally Advanced Flap in Isolated RT1 Recession (NCT07520539) | Cairo University | 2026-07-01 |
| Chidamide Monotherapy for Intermediate-to-High-Risk Myelodysplastic Syndromes (NCT07616336) | Zhongshan Hospital (Xiamen), Fudan University | 2026-07-01 |
| The Impact of Palatal Rugae Addition to Complete Dentures on Patients' Satisfaction and Oral Health Related Quality of Life (NCT07034079) | Pakistan Institute of Medical Sciences | 2026-07-01 |
| Clinical Investigation of Safety and Effectiveness for the enVVe® System (NCT07609927) | Hancock Jaffe Laboratiores, Inc | 2026-07-01 |
| Multiregion BHA in Open Tibia Fractures (NCT04056429) | Carmell Therapeutics Corporation | 2026-07-01 |
| Randomized Double-blind Controlled Clinical Study of SGLT-2i Combined With Probiotic Preparations in Elderly Patients With HFpEF (NCT07687212) | The First Affiliated Hospital of Air Force Medicial University | 2026-07-01 |
| A Trial on Fezolinetant for Vasomotor Symptoms in Men Receiving Androgen Deprivation Therapy (ADT) (NCT07568236) | Chinese University of Hong Kong | 2026-07-01 |
| Testing the SurVaxM Vaccine for Lung Cancer Prevention (NCT07169617) | National Cancer Institute (NCI) | 2026-07-01 |